New mathematical models suggest that for some cholera outbreaks, prescribing antibiotics more aggressively could slow or stop ...

The European Medicines Agency (EMA) has recommended marketing authorization for Tepezza (teprotumumab) for adults with ...

A new pilot study reveals that psilocybin—the compound found in psychedelic mushrooms—may significantly improve mood, ...

Xanamem is an investigational product and is not approved for use outside of a clinical trial by the FDA or by any global regulatory authority. Xanamem ® is a trademark of Actinogen Medical.

SCIENTISTS have urged people aged 45 to 65 to do a key activity in order to help prevent Alzheimer’s disease. Whether we ...

A survey of 1700 Americans 45 and older found that 79% would want to know if they were in the early stages of Alzheimer's.

This pilot study provides essential insights into how AI can augment traditional clinical workflows in diabetes management by ...

Making lifestyle adjustments could help you cut the risk of developing a stroke, dementia or late-life depression all at the ...

The World Health Organisation has warned that diphtheria, an acute and highly contagious bacterial disease that usually ...

Generally, Americans are optimistic about new treatments to slow or prevent Alzheimer’s. More than 4 out of 5 (81%) believe ...

Alzheimer’s early detection is now more accessible with blood tests, as survey data shows nearly 80% of Americans want to ...